Glibenclamide

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

25 Suppliers, 16 USDMF, 9 CEP/COS, 4 JDMF, 6 EU WC, 1 KDMF, 6 NDC API, 12 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

5 Suppliers

5 Suppliers

DOSSIERs // Finished Dosage Forms

184 Dossiers, 83 FDA Orange Book, 29 Europe, 9 Canada, 1 Australia, 19 South Africa, 43 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 1.25MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 36 Kerry, 27 BASF, 18 Roquette, 14 Corel Pharma Chem, 13 Seppic, 13 Microlex e.U, 12 Sigachi Industries, 11 Gangwal Chemicals, 9 Gangwal Healthcare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 SPI Pharma, 7 DFE Pharma, 6 Boai NKY Pharmaceuticals Ltd, 6 Lonza Capsugel, 6 Nanjing Well Pharmaceutical, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Ideal Cures Pvt Ltd, 5 Actylis, 4 Prachin Chemical, 4 Vasa Pharmachem, 4 Ingredion Pharma Solutions, 3 Kima Chemical, 3 Pharmatrans-Sanaq, 3 DKSH, 3 Ulanqab Kema New Material, 2 The Dow Chemical Company, 2 Aeon Procare, 2 Seqens, 2 Finar, 2 Clariant, 2 Evonik, 2 Jai Radhe Sales, 2 Nomisma Healthcare, 1 Qualicaps, 1 Avesta Pharma, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 Huzhou Sunflower Pharmaceutical Co. Ltd, 1 Nanjing Bold Chemical, 1 ACG Worldwide

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 48 Coating Systems & Additives, 38 Controlled & Modified Release, 38 Direct Compression, 31 Disintegrants & Superdisintegrants, 28 Solubilizers, 25 Granulation, 24 Thickeners and Stabilizers, 19 Film Formers & Plasticizers, 18 Lubricants & Glidants, 17 Topical, 15 Co-Processed Excipients, 14 Parenteral, 11 Taste Masking, 8 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 6 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 36 Finished Drug Prices

MARKET PLACE

14 APIs, 5 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

4 EDQM Standards, 3 USP Standards, 4 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 21 News

Pharmacy pricing data of Glibenclamide obtained from U.S. Medicaid's National Average Drug Acquisition Cost

Glibenclamide

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

25 Suppliers

16 USDMF

9 CEP/COS

4 JDMF

6 EU WC

1 KDMF

6 NDC API

12 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

5 Suppliers

DOSSIERs // Finished Dosage Forms

184 Dossiers

83 FDA Orange Book

29 Europe

9 Canada

1 Australia

19 South Africa

43 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 1.25MG

TABLET;ORAL - 2.5MG

TABLET;ORAL - 5MG

TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

36 Kerry

27 BASF

18 Roquette

14 Corel Pharma Chem

13 Seppic

13 Microlex e.U

12 Sigachi Industries

11 Gangwal Chemicals

9 Gangwal Healthcare

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 SPI Pharma

7 DFE Pharma

6 Boai NKY Pharmaceuticals Ltd

6 Lonza Capsugel

6 Nanjing Well Pharmaceutical

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Ideal Cures Pvt Ltd

5 Actylis

4 Prachin Chemical

4 Vasa Pharmachem

4 Ingredion Pharma Solutions

3 Kima Chemical

3 Pharmatrans-Sanaq

3 DKSH

3 Ulanqab Kema New Material

2 The Dow Chemical Company

2 Aeon Procare

2 Seqens

2 Finar

2 Clariant

2 Evonik

2 Jai Radhe Sales

2 Nomisma Healthcare

1 Qualicaps

1 Avesta Pharma

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Alcedo Pharmachem

1 Huzhou Sunflower Pharmaceutical Co. Ltd

1 Nanjing Bold Chemical

TABLET;ORAL - 1.25MG;250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 2.5MG;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 5MG;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons